PA
LFCR icon

Pinnacle Associates’s Lifecore Biomedical LFCR Stock Holding History

Pinnacle Associates’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-42,750
Closed -$558K – 707
2018
Q1 		$558K Sell
42,750
-2,800
-6% -$36.8K 0.01% 497
2017
Q4 		$574K Sell
45,550
-1,000
-2% -$12.6K 0.01% 483
2017
Q3 		$603K Sell
46,550
-7,950
-15% -$105K 0.01% 479
2017
Q2 		$809K Sell
54,500
-750
-1% -$10.4K 0.02% 425
2017
Q1 		$663K Buy
55,250
+16,650
+43% +$211K 0.01% 459
2016
Q4 		$533K Sell
38,600
-1,500
-4% -$20.8K 0.01% 477
2016
Q3 		$538K Buy
40,100
+10,650
+36% +$129K 0.01% 468
2016
Q2 		$317K Buy
29,450
+4,150
+16% +$45.8K 0.01% 532
2016
Q1 		$266K Sell
25,300
-10,350
-29% -$114K 0.01% 540
2015
Q4 		$422K Sell
35,650
-12,850
-26% -$158K 0.01% 479
2015
Q3 		$566K Buy
48,500
+2,900
+6% +$38.4K 0.01% 450
2015
Q2 		$658K Buy
45,600
+13,150
+41% +$190K 0.01% 433
2015
Q1 		$453K Buy
32,450
+15,400
+90% +$213K 0.01% 473
2014
Q4 		$235K Buy
+17,050
New +$220K ﹤0.01% 573

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Pinnacle Associates's LFCR Position: Q2 2018 in Review

Pinnacle Associates sold out of Lifecore Biomedical (LFCR) in Q2 2018, closing a stake of 42,750 shares — an estimated $558K sold.

Pinnacle Associates first reported a position in LFCR in Q4 2014 and held it in 14 quarters. The position peaked at $809K in Q2 2017. 92 funds tracked by Wall St. Rank hold LFCR as of Q2 2018.

  • Pinnacle Associates reported no remaining Lifecore Biomedical position as of Q2 2018 after selling out during the quarter.
  • Pinnacle Associates sold 42,750 Lifecore Biomedical shares in Q2 2018, an estimated $558K.
  • Pinnacle Associates first reported a position in Lifecore Biomedical in Q4 2014 and held it in 14 quarters.
  • Pinnacle Associates's Lifecore Biomedical position peaked at $809K in Q2 2017.
  • 92 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2018.

Based on Pinnacle Associates's 13F filing for Q2 2018, filed 8 Aug 2018.